American Well Corporation

NYSE:AMWL

Medical - Healthcare Information Services

Healthcare
$11.03 +2.82%

+$0.24 today

Market cap
$171.77M
Beta
1.70
P/E (TTM)
-1.6
EPS (TTM)
-$5.30
52W Low $3.71High $9.96

Volume 0.06M

Average 0.07M

AMWL Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

American Well CorporationNYSE: AMWL

Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026

Cost of revenue growth accelerates

Q1 FY2026 cost of revenue of $34.48M rose 9.2% year over year, ahead of the -18.1% change in trailing-twelve-month cost of revenue. Sequentially, it rose 27.8% from the prior quarter. Over 3 fiscal years it compounded at -10.1% a year.

Context

  • Cost of revenue amounted to 46.7% of revenue in FY2025, down 14.4 pp from a year earlier.
  • Cost of revenue increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +9.2% holds above the trailing-twelve-month pace of -18.1%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$34.48M+27.8% QoQ
Last fiscal yearDec 2025
$116.47M-25.1% YoY
LTMMar 2026
$119.38M-18.1% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+9.2%——
1 year-25.1%——
3-year CAGR-10.1%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
116.47M USD
Year-over-year change
-25.1%
4-year CAGR
-5.9%

Cost of Revenue vs competitors

How AMWL compares with its peers on the latest reported figures

  • AMWL's LTM Mar 2026 cost of revenue of $119.38M is the highest of the 9 companies compared; the peer median is $764.5K.
  • Its year-over-year change of -18.1% is the 3rd highest of 6, against a peer median of -31.8%.
  • Cost of revenue amounts to 50.3% of revenue for AMWL, versus a peer median of 39.9%.
AMWL Competitors Peer median
Cost of Revenue for AMWL and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AMWLAmerican Well CorporationLTM Mar 2026$119.38M -18.1%-10.1%50.3%
ATYRaTyr Pharma, Inc.LTM Mar 2026$22.52M +84.2%-2.9%11854.7%
EUDAEUDA Health Holdings LimitedLTM Jun 2026$6.82M +70.2%+9.8%56.0%
DTILPrecision BioSciences, Inc.LTM Mar 2026$1.37M ——3.0%
CAMPCAMP4 Therapeutics CorporationLTM Mar 2026$936K ——23.8%
BMEABiomea Fusion, Inc.LTM Mar 2026$593K ———
ALXOALX Oncology Holdings Inc.LTM Mar 2026$150K -31.8%——
IMUXImmunic, Inc.LTM Mar 2026$33K -50.0%——
GUTSFractyl Health, Inc. Common StockLTM Mar 2026$0 -100.0%——
Peer median (excluding AMWL) $764.5K-31.8%+3.4%39.9%

Competitors are the stored peer set for AMWL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue252.79M277.19M259.05M254.36M249.33M
Cost of Revenue148.47M160.42M164.29M155.41M116.47M
Gross Profit104.32M116.77M94.76M98.95M132.86M
Gross Margin41.3%42.1%36.6%38.9%53.3%
Research & Development106.59M138.49M105.83M86.07M72.86M
Selling, General & Admin160.78M227.98M213.11M197.45M131.31M
Operating Expenses283.46M392.62M786.9M316.49M238.13M
Depreciation & Amortization16.09M26.17M31.51M32.98M33.96M
EBITDA(166.07M)(245.84M)(224.15M)(176.91M)(60.57M)
EBITDA Margin-65.7%-88.7%-86.5%-69.6%-24.3%
Operating Income(179.15M)(275.85M)(692.14M)(217.53M)(105.27M)
Operating Margin-70.9%-99.5%-267.2%-85.5%-42.2%
Interest Income120K6.12M19.42M10.76M3.8M
Interest Expense00000
Other Income / Expenses(3.01M)3.85M16.83M7.65M10.74M
Income Before Tax(182.16M)(272.01M)(675.31M)(209.89M)(94.53M)
Pre-Tax Margin-72.1%-98.1%-260.7%-82.5%-37.9%
Income Tax Expense(5.38M)64K3.86M2.75M434K
Net Income(176.33M)(270.43M)(675.16M)(208.14M)(95.7M)
Net Margin-69.8%-97.6%-260.6%-81.8%-38.4%
EPS (Basic)(13.88)(19.68)(47.50)(13.88)(5.96)
EPS (Diluted)(13.88)(19.68)(47.50)(13.88)(5.96)
Weighted Avg Shares12.7M13.71M14.21M15M16.05M
Weighted Avg Shares (Diluted)12.7M13.71M14.21M15M16.05M

American Well Corporation

NYSE:AMWL

Intrinsic Alpha fair value

Locked

Current Price

$11.03

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.